SAN FRANCISCO, April 3, 2026 /PRNewswire/ — ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which ...

Immunotherapy and targeted therapy are often the first lines of treatment for advanced kidney cancer, with surgery and ...

Dr Thomas Flaig from the University of Colorado Anschutz discusses a paradigm shift in treating urothelial carcinoma patients ...

Positive high-level results from the EMERALD-3 Phase III trial showed AstraZeneca's Imfinzi (durvalumab) in combination with Imjudo (tremelimumab ...

A small molecule inside your body quietly fuels life every day. It helps your cells turn fat into energy, keeping your heart ...

Probability of Remaining Event-Free at 24 Months by Kaplan-Meier Analysis After Achieving Complete Response at Three Months ...

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get started with Staying Sharp. Follow this simple, flexible ...

This week in oncology, the FDA expanded the treatment landscape for platinum-resistant ovarian cancer with a new approval, and significant clinical data emerged regarding novel in ...

Treating early-stage prostate cancer was one thing, but Henard’s doctor at the small rural hospital nearby told him the new ...

Non–muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) continue to pose significant clinical and health-economic challenges in ...

Accelerated water-bath thawing, completed in about 25 minutes, may help streamline clinical workflows and support efficient patient management -- Label update includes data showing that product ...